Study Title

68Ga-NOTA-PEG2-RM26 PET/CT: Tracer Biodistribution and Uptake in Different Kinds of Cancer With Gastrin-Releasing Peptide Receptor (GRPR) Overexpression

Study Details

Description:

The gastrin-releasing peptide receptor (GRPR), also known as bombesin receptor subtype II (BB2), is a member of the G protein-coupled receptor family of bombesin receptors. GRPR is over-expressed in various types of human tumors. RM26, a GRPR antagonist with high affinity, was discovered by peptide backbone modification of bombesin analogues. To target gastrin-releasing peptide receptor in human neoplastic cells NOTA-PEG2-RM26 was synthesised and then labeled with 68Ga. An open-label whole-body PET/ CT study was designed to investigate the safety and dosimetry of 68Ga-NOTA-PEG2-RM26 and to assess its clinical diagnostic value in patients with cancer.

Contacts:

Antonios Tzortzakakis, MD, PhD

antonios.tzortzakakis@regionstockholm.se

08-123 70 000

Annette Fransson-Andreo-Hernandez, PhD

annette.fransson-andreo-hernandez@regionstockholm.se

+468 517 753 74

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468